Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ICLR | US
-9.09
-7.87%
Healthcare
Diagnostics & Research
30/06/2024
23/04/2026
106.34
107.43
110.05
104.03
ICON Public Limited Company a clinical research organization provides outsourced development and commercialization services in Ireland rest of Europe the United States and internationally. The company specializes in the strategic development management and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services including all phases of development peri and post approval data solutions and site and patient access services; and clinical research services including biostatistics clinical operations clinical supplies management covid-19 data management decentralized & hybrid clinical solutions endpoint adjudication services interactive response technologies investigator payments medical affairs medical writing and publishing pharmacovigilance and site and patient solutions. The company also provides laboratory services including bionanalytical biomarker vaccine good manufacturing practice and central laboratory services as well as full-service and functional service partnerships to customers. In addition it offers commercial positioning early phase language medical imaging and strategic solutions as well as clinical trial management consulting and contract staffing services. The company serves pharmaceutical biotechnology and medical device industries as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin Ireland.
View LessValue Stock (Price to Book < 3)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
52.4%1 month
47.1%3 months
101.8%6 months
78.9%34.54
18.02
2.55
0.37
0.21
16.99
3.30
1.09
1.72B
8.81B
8.81B
-
13.32
25.70
4.90
7.77
2.32
2.14
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
18.50
Range1M
23.93
Range3M
124.43
Rel. volume
2.36
Price X volume
240.33M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Charles River Laboratories International Inc | CRL | Diagnostics & Research | 167.74 | 8.66B | -9.23% | 23.63 | 76.32% |
| QIAGEN N.V | QGEN | Diagnostics & Research | 37.97 | 8.44B | -5.00% | 122.86 | 41.16% |
| Bio-Rad Laboratories Inc | BIO | Diagnostics & Research | 281.42 | 7.80B | -6.44% | n/a | 20.54% |
| Lantheus Holdings Inc | LNTH | Diagnostics & Research | 82.82 | 5.75B | -0.07% | 19.19 | 60.42% |
| Bruker Corporation | BRKR | Diagnostics & Research | 36.22 | 5.48B | -8.70% | 26.13 | 126.86% |
| Sotera Health Company | SHC | Diagnostics & Research | 15.33 | 4.34B | -1.92% | 114.29 | 555.18% |
| Celcuity Inc | CELC | Diagnostics & Research | 113.56 | 4.21B | -7.24% | n/a | 54.62% |
| RadNet Inc | RDNT | Diagnostics & Research | 56.44 | 4.17B | -2.40% | 378.67 | 195.04% |
| Senseonics Holdings Inc | SENS | Diagnostics & Research | 7 | 3.75B | n/a | 154.97% | |
| Twist Bioscience Corporation | TWST | Diagnostics & Research | 58.85 | 3.45B | -6.88% | n/a | 17.75% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Dolby Laboratories Inc | DLB | Media - Diversified | 62.96 | 6.00B | -3.03% | 34.32 | 0.00% |
| FBIN | FBIN | Building Products & Equipment | 41.4 | 5.14B | 2.15% | 25.57 | 130.24% |
| Thor Industries Inc | THO | Recreational Vehicles | 78.81 | 4.17B | 1.04% | 23.44 | 27.88% |
| Cinemark Holdings Inc | CNK | Media - Diversified | 28.6 | 3.50B | 0.25% | 27.93 | 934.91% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 26.99 | 3.36B | -6.90% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 59.41 | 3.31B | 1.50% | 14.48 | 170.51% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 23.38 | 3.08B | 1.96% | 7.33 | 218.58% |
| LCI Industries | LCII | Recreational Vehicles | 120.55 | 3.07B | 0.73% | 25.82 | 77.66% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 15.37 | 2.76B | 0.99% | n/a | -571.93% |
| IMAX Corporation | IMAX | Media - Diversified | 36.61 | 1.93B | 1.08% | 54.26 | 110.44% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 16.99 | 12.67 | Expensive |
| Ent. to Revenue | 3.30 | 44.00 | Cheaper |
| PE Ratio | 34.54 | 40.09 | Par |
| Price to Book | 2.55 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 101.80 | 59.59 | Riskier |
| Debt to Equity | 0.37 | -14.36 | Expensive |
| Debt to Assets | 0.21 | 0.34 | Cheaper |
| Market Cap | 8.81B | 13.71B | Emerging |